Public Relations (PR)

Timeline of a crisis: How Mylan responded to the EpiPen controversy

Timeline of a crisis: How Mylan responded to the EpiPen controversy

By

Mylan was slammed by people unable to afford its lifesaving EpiPen injection device following a price hike — its response was seen as too little, too late.

Ketchum promotes McCarthy, hires new head of healthcare

Ketchum promotes McCarthy, hires new head of healthcare

By

Tom Jones joined Ketchum after serving as head of healthcare at Makovsky.

Best Use of Public Relations of 2016

Best Use of Public Relations of 2016

By

Judges rated the Perfectly Imperfect campaign as smart, creative, unique, empowering, and perfectly aligned.

Health exchanges, Obama administration challenged by recent insurer exits

Health exchanges, Obama administration challenged by recent insurer exits

By

The pull-back of insurance providers has left state-run health exchanges and the Obama administration facing a difficult communications challenge.

W2O sells stake to private-equity firm

W2O sells stake to private-equity firm

By

The agency network said the private equity firm won't be involved in its day-to-day operations, but it will help its growth strategy.

Omnicom PR Group acquires healthcare shop Rabin Martin

Omnicom PR Group acquires healthcare shop Rabin Martin

By

It is the group's first acquisition since it was assembled in February under CEO Karen van Bergen.

Q&A: Toby Cosgrove on running the Cleveland Clinic and community comms

Q&A: Toby Cosgrove on running the Cleveland Clinic and community comms

By

The Cleveland Clinic's CEO discusses how he keeps the hospital on top of its game and educates the community it serves.

W2O, Lagrant Foundation team up on healthcare diversity push

W2O, Lagrant Foundation team up on healthcare diversity push

By

The healthcare-focused agency network is committed to spending $50,000 over three years to the Future Leaders in Healthcare Fellowship Program.

AstraZeneca hires new head of corporate affairs

AstraZeneca hires new head of corporate affairs

By

AstraZeneca appointed Jennie Younger, who has held senior communications roles at GlaxoSmithKline, Deutsche Bank, and FTI Consulting, as its vice president of global corporate affairs.

Hill+Knowlton Strategies taps new U.S. health practice lead

Hill+Knowlton Strategies taps new U.S. health practice lead

By

The agency brought on Penny Mitchell to lead its U.S. health practice.

Ascension Health ups Ragone to chief marcomms officer

Ascension Health ups Ragone to chief marcomms officer

By

The Ketchum veteran joined the nonprofit healthcare system in mid-2014.

Johnson & Johnson comms leader stepping down

Johnson & Johnson comms leader stepping down

By

FitzPatrick is departing the company as it evaluates its 150 agency partnerships.

InVentiv Health PR promotes O'Kane to MD

InVentiv Health PR promotes O'Kane to MD

By

Former Biosector 2 US MD Jeanine O'Kane was named inVentiv Health PR Group's US MD.

Weber Shandwick buys healthcare specialist ReviveHealth

Weber Shandwick buys healthcare specialist ReviveHealth

By

Nashville-based ReviveHealth posted $8.7 million in revenue in 2014.

DCI Group aids Turing amid drug price, Shkreli controversies

DCI Group aids Turing amid drug price, Shkreli controversies

By

The firm began working with the pharma company before outrage over its drug pricing but has more recently supported the client after former CEO Martin Shkreli was arrested.

Paul Newman to lead Takeda's vaccines comms

Paul Newman to lead Takeda's vaccines comms

By

The former MSL regional leader reemerges as head of communications at Japan's largest pharma company.

Pfizer taps corporate affairs leads as part of reorganization

Pfizer taps corporate affairs leads as part of reorganization

By

Pfizer selected MacKay Jimeson and Niesha Foster as corporate affairs category leads after a reorganization of the company's global innovative pharma business.

Edelman signs China health comms partnership

Edelman signs China health comms partnership

The agency will team up with Tsinghua Institute of Health Communication on study on how consumers interact with healthcare content.

Why drug companies need to go from reactive to proactive on pricing

Why drug companies need to go from reactive to proactive on pricing

By

Drug pricing has been in the spotlight since early this fall, thanks to Turing Pharmaceuticals and Martin Shkreli. One thing pharma companies can do is to communicate more proactively.

Editor's Desk: Escaping the Shkreli Cycle

Editor's Desk: Escaping the Shkreli Cycle

By

Three suggestions for defusing the highly charged pricing atmosphere

Theranos fights back against scrutinizing WSJ reports with 6,000-word post

Theranos fights back against scrutinizing WSJ reports with 6,000-word post

By

Theranos posted the lengthy response on the news section of its website on Thursday, then bragged on Twitter that its statement was 3,000 words longer than the WSJ story.

Valeant's controversial model undergoing changes, says CEO

Valeant's controversial model undergoing changes, says CEO

By

The drugmaker, which recently drew scrutiny from lawmakers, is planning to change some of its most contentious business practices. Experts say Valeant also needs to educate lawmakers and the public about the value of its medicines.

GCI Health ups Cahill to North America president

GCI Health ups Cahill to North America president

By

Sherry Goldberg will replace her as New York market leader.

Finn Partners names Kuhl senior partner

Finn Partners names Kuhl senior partner

By

Kristie Kuhl, previously EVP at Cohn & Wolfe, is tasked with building out the agency's pharmaceutical business.

Six things for pharma marketers to know: Thursday, October 8, 2015

Six things for pharma marketers to know: Thursday, October 8, 2015

By

Sanofi's Aubagio reduces brain volume loss; cancer specialists avoid pricey cancer meds; analysis says placebo effect is on the rise

New Turing CCO steps down amid drug price controversy

New Turing CCO steps down amid drug price controversy

By

Craig Rothenberg joined Turing as its first comms chief less than two months ago.

Pfizer's Susman: Customer-company relationship has changed

Pfizer's Susman: Customer-company relationship has changed

By

Stakeholder activists, social media and an increasingly global market are three defining issues for companies operating in the 21st century.

WebMD's Holland joins MWW's corporate health practice

WebMD's Holland joins MWW's corporate health practice

Holland most recently worked as executive director of public health solutions at WebMD.

7 questions for new Turing Pharmaceuticals comms chief Craig Rothenberg

7 questions for new Turing Pharmaceuticals comms chief Craig Rothenberg

After two decades at Johnson & Johnson, Craig Rothenberg talks about joining a startup and the role of comms in pharma.

Savvy comms paves way for Walgreens Boots Alliance merger

Savvy comms paves way for Walgreens Boots Alliance merger

Walgreens Boots Alliance's global comms team works hand in hand to balance the complexities of a merger and create a unified strategy to inspire all stakeholders.

OPINION

Email Newsletters